REDMOND, WA - Nutraceutix, Inc. (OTC BB: NUTX), a leading provider of patented technologies and products for the nutraceutical and pharmaceutical industries, has entered a licensing agreement with Canadian-based Nutravite to package, market and distribute Nutraceutix's Controlled Delivery Technology (CDT™)-Glucosamine and CDT™-Glucosamine-Chondroitin products in the Canadian marketplace. For Nutraceutix, the agreement extends its patented CDT™ Glucosamine products to the growing Canadian market with the assistance of Nutravite, an established and growing manufacturer of herbal and dietary supplements company. Nutravite, an ISO9002 certified and Therapeutic Products Program (TPP) inspected company, will expand its established Glucosamine franchise by offering unique once-daily dosage Glucosamine products and technologies under the Nutravite label to the Canadian health food market, retail pharmacies and mass merchandisers.
According to Farid Ibrahim, President and CEO of Nutravite, "We are very excited about the opportunity to add Controlled Delivery Glucosamine products to our line. It fits well with our corporate strategy. Nutravite takes pride in its history of being first to market with leading-edge natural health products. The CDT Glucosamine products offer a clear therapeutic advantage over what is currently available in the Canadian marketplace." For more information, visit the Nutravite website at: http://www.nutravite.com/.
David T. Howard, President and CEO of Nutraceutix, adds, " We are gratified that Nutravite has rapidly succeeded in listing the CDT™-Glucosamine products with such stores as Wal-Mart Canada, Herbies, Hy & Zels, Pharma Plus, and Pharmx Rexall. This is our first CDT™ product to be offered outside the United States, and its acceptance by major Canadian retail pharmacy chains is encouraging validation. We look forward to a mutually beneficial relationship with Nutravite, and appreciate their efforts to make our patented CDT technology available to Canadian customers."
Based in Redmond, Washington, Nutraceutix, Inc. is a biopharmaceutical company leveraging specialized knowledge, proprietary and patented products and technologies such as LiveBac® Probiotics and the patented CDT™ Controlled Delivery Technology platform to introduce distinctive and novel OTC products, prescription drugs and dietary supplements.
Nutraceutix technologies provide distinctive products with tangible benefits for the consumer and competitive commercial advantages for retailers. Established partnerships with pharmaceutical, OTC and natural products industry companies enables Nutraceutix to co-develop new products and to add value and protection to existing product franchises. For more information on Nutraceutix, please call 1.800.548.3222 or visit http://www.nutraceutix.com/.
Except for any historical information, the matters discussed in this press release contain forward-looking statements, including activities; events or developments that the company expects, believes or anticipates will or may occur in the future. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statement.